“Predictive role of CCND1, FGFR1 gene amplifications and PIK3CA mutations for endocrine therapy of primary metastatic breast cancer ”, Вопр. онкол., vol. 67, no. 5, pp. 646–657, Oct. 2021, doi: 10.37469/0507-3758-2021-67-5-646-657.